Literature DB >> 9492466

[Intralobar pulmonary sequestration with three aberrant arteries: a case report and review of the Japanese literature].

T Jotsuka1, H Matsuguma, M Sawafuji, K Yokoi, T Hirose, K Mori, K Tominaga, G Imura.   

Abstract

A case of intralobar pulmonary sequestration with three aberrant arteries was reported. The patient was a 26-year-old man. His chest film showed an abnormal shadow suspected of a pulmonary sequestration in the left lower lobe of the lung. Computed tomography of the chest revealed that the aberrant arteries originated from the descending aorta and circulated the emphysematous area of the left lung. Angiography clearly demonstrated three aberrant arteries and three veins draining into the hemiazygos and lower pulmonary veins. Pulmonary sequestration was diagnosed and then resected. Microscopically, the resected lung had emphysematous change, multiple cysts and winded vessels. Aberrant arteries were the elastic type of vessels and accompanied with atherosclerosis. According to the review of 139 Japanese cases of intralobar pulmonary sequestration, 7% of all patients had more than two aberrant arteries. Moreover, only 3% of patients had veins draining into the systemic vessels. In many cases the thin aberrant arteries were clearly demonstrated by angiography and the draining veins were detected. We consider that angiography is necessary to show definitely the aberrant arteries and drainage veins.

Entities:  

Mesh:

Year:  1998        PMID: 9492466

Source DB:  PubMed          Journal:  Kyobu Geka        ISSN: 0021-5252


  2 in total

1.  Intralobar pulmonary sequestration: an uncommon case with triple arterial supply and systemic venous drainage.

Authors:  Ioannis Theodoropoulos; Marshall Z Schwartz
Journal:  Pediatr Surg Int       Date:  2012-04-18       Impact factor: 1.827

2.  Vascular Anatomy in Congenital Lung Lesions-Description and Classification.

Authors:  Simon Kargl; Florian Schlader; Mario Scala; Julian Kammel
Journal:  Front Pediatr       Date:  2022-05-12       Impact factor: 3.569

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.